What is E-Base? E-Base (Erythromycin) is a macrolide antibiotic used to treat bacterial infections. It may also be used to prevent bacterial infections in patients with rheumatic heart disease. Your pharmacist may know of alternate uses for E-Base (Erythromycin). Read more on E-Base.
What is Generic E-Base?
Generic E-Base, like all generics, is the name given to the
prescription Erythromycin medication manufactured by any company other than the
original inventor of E-Base. The only true difference between brand name E-Base
and generic E-Base is that generic E-Base is always less expensive.
Related products: Akne-Mycin, Apo-Erythro, Arpimycin, Benzamycin, Colitromin, E-Mycin, Eritromicina, Ermysin, Ery Tab, Eryacne, ERYC, Erycette, Erycin, Erycinum, EryDerm, Erymax, Erythro, Erythrocin, Erythromid, Erythroped, Ilosone, Ilotycin, Novo-rythro Encap, PCE, Retcin, Rommix, Staticin, Stiemycin, Theramycin Z, Tiloryth, T-Stat, Wintrocin, Erythromycin (generic name).
Generic E-Base is at OpenRxShop
|*** SAVE 5% to 10% MORE WITH DISCOUNT COUPON: MAvU6EZMU3 ***|
Generic E-Base , Benzamycin, E-Mycin Grans Oral Susp, and Erycin are at Freedom Pharmacy
|*** SAVE 5% MORE WITH DISCOUNT CODE: MYN-05 ***|
|Benzamycin||46.6 g||5 % topical gel||$89.97||Order|
|E-Mycin Grans Oral Susp||200 mg||100ml||$50.96||Order|
|E-Mycin Grans Oral Susp||200 mg||300ml||$89.54||Order|
|E-Mycin Grans Oral Susp||200 mg||600ml||$136.82||Order|
|E-Mycin Grans Oral Susp||400 mg||100ml||$55.26||Order|
|E-Mycin Grans Oral Susp||400 mg||300ml||$102.40||Order|
|E-Mycin Grans Oral Susp||400 mg||600ml||$162.54||Order|
|Erycin||250 mg||10 tablets||$23.23||Order|
|Erycin||500 mg||10 tablets||$27.87||Order|
Buy Generic E-Base - No Prior Prescription Needed*
How To Buy Generic E-Base Online
Buy discount generic E-Base (Erythromycin) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
E-Base - Health Bulletin
Biologic Drug Approved to Prevent Hepatitis B in Liver Recipients
FRIDAY, April 6 (HealthDay News) -- HepaGam B, a first-of-its-kind immune globulin product, has been approved by the U.S. Food and Drug Administration to prevent hepatitis B reinfection among people who have received liver transplants, the agency said Friday.
Immune-compromised liver transplant recipients who have already been exposed to hepatitis B are at increased risk of re-infection from the virus, which attacks the liver and can cause liver failure or liver cancer. HepaGam B, produced from human plasma, stimulates an immune response to the virus, the FDA said.Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.